114 related articles for article (PubMed ID: 37997502)
1. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1.
Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
3. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
6.
Luan Q; Yang R; Lin L; Li X
Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
[TBL] [Abstract][Full Text] [Related]
7. LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels.
Zhao H; Zhu X; Luo Y; Liu S; Wu W; Zhang L; Zhu J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786631
[TBL] [Abstract][Full Text] [Related]
8. PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1.
Wang YW; Zhu WJ; Ma RR; Tian YR; Chen X; Gao P
J Cell Mol Med; 2024 Jan; 28(1):e18022. PubMed ID: 37929660
[TBL] [Abstract][Full Text] [Related]
9. CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
Li X; Yang S; Zhao C; Yang J; Li C; Shen W; Hu H; Zhang W; Yang S
Endocr J; 2021 Aug; 68(8):1011-1025. PubMed ID: 34092745
[TBL] [Abstract][Full Text] [Related]
10. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract][Full Text] [Related]
11. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
Qi F; Tang J; Cai Z; Wang G; Wang Z
Bioengineered; 2022 Mar; 13(3):7592-7606. PubMed ID: 35264071
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract][Full Text] [Related]
14. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2.
Qiu K; Xie Q; Jiang S; Lin T
J Clin Lab Anal; 2020 Feb; 34(2):e23044. PubMed ID: 31670857
[TBL] [Abstract][Full Text] [Related]
15. STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis.
Wang YL; Ren D; Lu JL; Jiang H; Wei JZ; Lan J; Liu F; Qu SH
Lab Invest; 2022 Sep; 102(9):919-934. PubMed ID: 35562411
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
Yan J; Dai P; Qin X; He Y; Zhang Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
[TBL] [Abstract][Full Text] [Related]
17. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
Liu DK; Yu S; Li JP; Song WW; Li JH
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
[TBL] [Abstract][Full Text] [Related]
18. IncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway.
Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
Crit Rev Eukaryot Gene Expr; 2022; 33(1):1-14. PubMed ID: 36374807
[TBL] [Abstract][Full Text] [Related]
19. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
